1. Home
  2. LFMD vs ABUS Comparison

LFMD vs ABUS Comparison

Compare LFMD & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMD
  • ABUS
  • Stock Information
  • Founded
  • LFMD 1994
  • ABUS 2005
  • Country
  • LFMD United States
  • ABUS United States
  • Employees
  • LFMD N/A
  • ABUS N/A
  • Industry
  • LFMD Medical/Nursing Services
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFMD Health Care
  • ABUS Health Care
  • Exchange
  • LFMD Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • LFMD 619.0M
  • ABUS 611.0M
  • IPO Year
  • LFMD N/A
  • ABUS N/A
  • Fundamental
  • Price
  • LFMD $11.26
  • ABUS $3.13
  • Analyst Decision
  • LFMD Strong Buy
  • ABUS Strong Buy
  • Analyst Count
  • LFMD 5
  • ABUS 4
  • Target Price
  • LFMD $12.20
  • ABUS $5.50
  • AVG Volume (30 Days)
  • LFMD 1.9M
  • ABUS 869.3K
  • Earning Date
  • LFMD 08-06-2025
  • ABUS 07-31-2025
  • Dividend Yield
  • LFMD N/A
  • ABUS N/A
  • EPS Growth
  • LFMD N/A
  • ABUS N/A
  • EPS
  • LFMD N/A
  • ABUS N/A
  • Revenue
  • LFMD $234,007,330.00
  • ABUS $6,403,000.00
  • Revenue This Year
  • LFMD $29.80
  • ABUS $3.35
  • Revenue Next Year
  • LFMD $18.03
  • ABUS N/A
  • P/E Ratio
  • LFMD N/A
  • ABUS N/A
  • Revenue Growth
  • LFMD 43.07
  • ABUS N/A
  • 52 Week Low
  • LFMD $3.99
  • ABUS $2.71
  • 52 Week High
  • LFMD $15.84
  • ABUS $4.73
  • Technical
  • Relative Strength Index (RSI)
  • LFMD 39.59
  • ABUS 41.34
  • Support Level
  • LFMD $11.63
  • ABUS $3.11
  • Resistance Level
  • LFMD $14.43
  • ABUS $3.36
  • Average True Range (ATR)
  • LFMD 0.83
  • ABUS 0.13
  • MACD
  • LFMD -0.39
  • ABUS -0.01
  • Stochastic Oscillator
  • LFMD 0.76
  • ABUS 19.78

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: